Skip to main content
. 2020 Oct 22;11:582657. doi: 10.3389/fimmu.2020.582657

Figure 1.

Figure 1

The cross-regulation between Bregs and tumors. In the tumor microenvironment, Bregs suppress effector T cells, induce regulatory T cells and target other tumor-infiltrating immune cells, such as myeloid-derived suppressor cells, natural killer cells and macrophages, to hamper anti-tumor immunity. Meanwhile, the cross-regulations between Bregs and tumor cells often result in tumor escape from immunosurveillance.